Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocannabinoid metabolic pathways and enzymes.

Alessia Ligresti1, Maria Grazia Cascio, Vincenzo Di Marzo

  • 1Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Comprensorio Olivetti, Fabbr. 70, 80078 Pozzuoli (NA), Italy.

Current Drug Targets. CNS and Neurological Disorders
|December 27, 2005
PubMed
Summary

This review covers endocannabinoids, their synthesis and breakdown pathways, and key enzymes. Understanding these endocannabinoid enzymes is crucial for potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabinoid receptors orchestrate distinct anti-tumour pathways in gastric cancer via and beyond specialized pro-resolving mediators.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain.

International journal of molecular sciences·2026
Same author

Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.

Journal of medicinal chemistry·2025
Same author

Profiling Allosteric Modulators of CB<sub>1</sub>R with an Allosteric Fluoroprobe.

Angewandte Chemie (International ed. in English)·2025
Same author

<i>N</i>-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R).

Journal of medicinal chemistry·2024
Same author

DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation.

Computers in biology and medicine·2024

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Endocannabinoids are endogenous agonists of cannabinoid receptors, identified in 1995.
  • They play a role in regulating physiological processes.
  • Anandamide and 2-arachidonoylglycerol (2-AG) are the primary endocannabinoids.

Purpose of the Study:

  • To review the anabolic and catabolic pathways of endocannabinoids.
  • To discuss the enzymes involved in endocannabinoid metabolism.
  • To explore the therapeutic potential of targeting these enzymes.

Main Methods:

  • Literature review of endocannabinoid research.
  • Analysis of cloned endocannabinoid enzymes and their functions.
  • Discussion of regulatory strategies for endocannabinoid levels.

Related Experiment Videos

Main Results:

  • Five key endocannabinoid enzymes have been identified and cloned.
  • Two enzymes (NAPE-selective phospholipase D and fatty acid amide hydrolase) are involved in anandamide metabolism.
  • Three enzymes (sn-1-selective diacylglycerol lipases alpha and beta, and monoacylglycerol lipase) are involved in 2-AG metabolism.

Conclusions:

  • A general strategy appears to regulate the levels of major endocannabinoids.
  • These enzymes represent potential therapeutic targets.
  • Alternative metabolic pathways for endocannabinoids may exist.